Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein
The bloodstream developmental stages of the protozoan parasite Trypanosoma brucei brucei are lysed by normal human serum. The cytotoxic factor is a minor sub-class of human high-density lipoprotein termed trypanosome lyric factor (TLF). T. b. brucei rapidly develops resistance to TLF when incubated...
Gespeichert in:
Veröffentlicht in: | Experimental parasitology 1995-09, Vol.81 (2), p.216-226 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 226 |
---|---|
container_issue | 2 |
container_start_page | 216 |
container_title | Experimental parasitology |
container_volume | 81 |
creator | Moore, D.R. Smith, A. Hager, K.M. Waldon, R. Esko, J.D. Hajduk, S.L. |
description | The bloodstream developmental stages of the protozoan parasite Trypanosoma brucei brucei are lysed by normal human serum. The cytotoxic factor is a minor sub-class of human high-density lipoprotein termed trypanosome lyric factor (TLF). T. b. brucei rapidly develops resistance to TLF when incubated at 26°C under conditions which allow differentiation to the procyclic, insect midgut developmental stage. This in vitro differentiation system allowed us to correlate loss of TLF sensitivity with other parameters of differentiation to the procyclic form. The onset of resistance to TLF occurs within 2 hr after shifting bloodstream forms to differentiation conditions. TLF resistance is correlated with a rapid but transient decrease in protein synthesis by the parasite, is acquired prior to cell division at 26°C, and precedes the loss of variant surface glycoprotein. Tn addition, we found binding and uptake of TLF by established procyclic trypanosomes was reduced approximately fivefold relative to bloodstream trypanosomes and the TLF binding observed in procyclics was nonspecific. No TLF was bound to the procyclic flagellar pocket membrane and the procyclics failed to endocytose any of the surface-bound TLF. In contrast, bloodstream forms bind TLF via a flagellar pocket-localized protein and bound TLF is taken up;by endocytosis. These findings suggest that resistance of procyclic T. b. brucei to TLF-mediated lysis is due to a reduction in the endocytosis of TLF by this developmental stage of the parasite. |
doi_str_mv | 10.1006/expr.1995.1111 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17002776</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014489485711113</els_id><sourcerecordid>17002776</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-bee4566459d448ca22198737af617588915f1804bb9bbf7355088040b96b8fb23</originalsourceid><addsrcrecordid>eNp1kEGP1CAYhhujWcfVqwcTkx7M3jpCBygczeyuYzKJibt7JkA_ZjFtqUAn24P_XeqMe5PLF_I-vMBTFO8xWmOE2Gd4GsMaC0HXOK8XxQojgaqaEPGyWCGESUW4IK-LNzH-RAhxXJOL4qKhlFFGVsXvazhC58cehqS6bi5_wGHqVIK2vIMhuuSOLs2lt-V9mEc1-Oh7VeowGXD_RvJleoRyOyef_JMz5Y21YFJcTu2mXg3lzh0eq-u_fXO5d6Mfg0_ghrfFK6u6CO_O87J4uL253-6q_fev37Zf9pUhmKdKAxDKGKGiJYQbVddY8GbTKMtwQzkXmFrMEdFaaG2bDaWI5y3Sgmludb25LK5OvfneXxPEJHsXDXSdGsBPUeIGobppWAbXJ9AEH2MAK8fgehVmiZFcfMvFt1x8y8V3PvDx3DzpHtpn_Cw455_OuYpGdTaowbj4jG1YQzdsqflwwqzyUh1CRh7uRP4zJSKH_BRCVnR0EGQ0DgYDrQvZs2y9-9_z_gA8tqWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17002776</pqid></control><display><type>article</type><title>Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Moore, D.R. ; Smith, A. ; Hager, K.M. ; Waldon, R. ; Esko, J.D. ; Hajduk, S.L.</creator><creatorcontrib>Moore, D.R. ; Smith, A. ; Hager, K.M. ; Waldon, R. ; Esko, J.D. ; Hajduk, S.L.</creatorcontrib><description>The bloodstream developmental stages of the protozoan parasite Trypanosoma brucei brucei are lysed by normal human serum. The cytotoxic factor is a minor sub-class of human high-density lipoprotein termed trypanosome lyric factor (TLF). T. b. brucei rapidly develops resistance to TLF when incubated at 26°C under conditions which allow differentiation to the procyclic, insect midgut developmental stage. This in vitro differentiation system allowed us to correlate loss of TLF sensitivity with other parameters of differentiation to the procyclic form. The onset of resistance to TLF occurs within 2 hr after shifting bloodstream forms to differentiation conditions. TLF resistance is correlated with a rapid but transient decrease in protein synthesis by the parasite, is acquired prior to cell division at 26°C, and precedes the loss of variant surface glycoprotein. Tn addition, we found binding and uptake of TLF by established procyclic trypanosomes was reduced approximately fivefold relative to bloodstream trypanosomes and the TLF binding observed in procyclics was nonspecific. No TLF was bound to the procyclic flagellar pocket membrane and the procyclics failed to endocytose any of the surface-bound TLF. In contrast, bloodstream forms bind TLF via a flagellar pocket-localized protein and bound TLF is taken up;by endocytosis. These findings suggest that resistance of procyclic T. b. brucei to TLF-mediated lysis is due to a reduction in the endocytosis of TLF by this developmental stage of the parasite.</description><identifier>ISSN: 0014-4894</identifier><identifier>EISSN: 1090-2449</identifier><identifier>DOI: 10.1006/expr.1995.1111</identifier><identifier>PMID: 7556564</identifier><identifier>CODEN: EXPAAA</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>ANIMAL DEVELOPMENTAL STAGES ; Animals ; Biological and medical sciences ; Biological Transport ; BLOOD SERUM ; Cell Differentiation ; CYTOTOXICITY ; Cytotoxins ; Drug Resistance ; Endocytosis ; ETAPAS DEL DESARROLLO ANIMAL ; Experimental protozoal diseases and models ; Female ; Fluorescent Antibody Technique ; GENERO HUMANO ; GENRE HUMAIN ; Humans ; Infectious diseases ; LIPOPROTEINAS ; LIPOPROTEINE ; LIPOPROTEINS ; Lipoproteins, HDL - metabolism ; Lipoproteins, HDL - pharmacology ; MANKIND ; Medical sciences ; Parasitic diseases ; PROCYCLIC TRYPANOSOMES ; Protein Binding ; Protozoal diseases ; Protozoan Proteins - biosynthesis ; Rats ; RESISTANCE ; SERUM SANGUIN ; STADE DE DEVELOPPEMENT ANIMAL ; SUERO SANGUINEO ; SUSCEPTIBILITY ; TOXICIDAD ; TOXICITE ; TOXICITY ; Toxicity Tests ; Trypanocidal Agents - blood ; Trypanocidal Agents - metabolism ; Trypanocidal Agents - pharmacology ; TRYPANOSOMA BRUCEI ; Trypanosoma brucei brucei ; Trypanosoma brucei brucei - drug effects ; Trypanosoma brucei brucei - growth & development ; Trypanosoma brucei brucei - ultrastructure ; TRYPANOSOME LYTIC FACTOR ; Variant Surface Glycoproteins, Trypanosoma - analysis</subject><ispartof>Experimental parasitology, 1995-09, Vol.81 (2), p.216-226</ispartof><rights>1995 Academic Press</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-bee4566459d448ca22198737af617588915f1804bb9bbf7355088040b96b8fb23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/expr.1995.1111$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3675361$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7556564$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moore, D.R.</creatorcontrib><creatorcontrib>Smith, A.</creatorcontrib><creatorcontrib>Hager, K.M.</creatorcontrib><creatorcontrib>Waldon, R.</creatorcontrib><creatorcontrib>Esko, J.D.</creatorcontrib><creatorcontrib>Hajduk, S.L.</creatorcontrib><title>Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein</title><title>Experimental parasitology</title><addtitle>Exp Parasitol</addtitle><description>The bloodstream developmental stages of the protozoan parasite Trypanosoma brucei brucei are lysed by normal human serum. The cytotoxic factor is a minor sub-class of human high-density lipoprotein termed trypanosome lyric factor (TLF). T. b. brucei rapidly develops resistance to TLF when incubated at 26°C under conditions which allow differentiation to the procyclic, insect midgut developmental stage. This in vitro differentiation system allowed us to correlate loss of TLF sensitivity with other parameters of differentiation to the procyclic form. The onset of resistance to TLF occurs within 2 hr after shifting bloodstream forms to differentiation conditions. TLF resistance is correlated with a rapid but transient decrease in protein synthesis by the parasite, is acquired prior to cell division at 26°C, and precedes the loss of variant surface glycoprotein. Tn addition, we found binding and uptake of TLF by established procyclic trypanosomes was reduced approximately fivefold relative to bloodstream trypanosomes and the TLF binding observed in procyclics was nonspecific. No TLF was bound to the procyclic flagellar pocket membrane and the procyclics failed to endocytose any of the surface-bound TLF. In contrast, bloodstream forms bind TLF via a flagellar pocket-localized protein and bound TLF is taken up;by endocytosis. These findings suggest that resistance of procyclic T. b. brucei to TLF-mediated lysis is due to a reduction in the endocytosis of TLF by this developmental stage of the parasite.</description><subject>ANIMAL DEVELOPMENTAL STAGES</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Biological Transport</subject><subject>BLOOD SERUM</subject><subject>Cell Differentiation</subject><subject>CYTOTOXICITY</subject><subject>Cytotoxins</subject><subject>Drug Resistance</subject><subject>Endocytosis</subject><subject>ETAPAS DEL DESARROLLO ANIMAL</subject><subject>Experimental protozoal diseases and models</subject><subject>Female</subject><subject>Fluorescent Antibody Technique</subject><subject>GENERO HUMANO</subject><subject>GENRE HUMAIN</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>LIPOPROTEINAS</subject><subject>LIPOPROTEINE</subject><subject>LIPOPROTEINS</subject><subject>Lipoproteins, HDL - metabolism</subject><subject>Lipoproteins, HDL - pharmacology</subject><subject>MANKIND</subject><subject>Medical sciences</subject><subject>Parasitic diseases</subject><subject>PROCYCLIC TRYPANOSOMES</subject><subject>Protein Binding</subject><subject>Protozoal diseases</subject><subject>Protozoan Proteins - biosynthesis</subject><subject>Rats</subject><subject>RESISTANCE</subject><subject>SERUM SANGUIN</subject><subject>STADE DE DEVELOPPEMENT ANIMAL</subject><subject>SUERO SANGUINEO</subject><subject>SUSCEPTIBILITY</subject><subject>TOXICIDAD</subject><subject>TOXICITE</subject><subject>TOXICITY</subject><subject>Toxicity Tests</subject><subject>Trypanocidal Agents - blood</subject><subject>Trypanocidal Agents - metabolism</subject><subject>Trypanocidal Agents - pharmacology</subject><subject>TRYPANOSOMA BRUCEI</subject><subject>Trypanosoma brucei brucei</subject><subject>Trypanosoma brucei brucei - drug effects</subject><subject>Trypanosoma brucei brucei - growth & development</subject><subject>Trypanosoma brucei brucei - ultrastructure</subject><subject>TRYPANOSOME LYTIC FACTOR</subject><subject>Variant Surface Glycoproteins, Trypanosoma - analysis</subject><issn>0014-4894</issn><issn>1090-2449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEGP1CAYhhujWcfVqwcTkx7M3jpCBygczeyuYzKJibt7JkA_ZjFtqUAn24P_XeqMe5PLF_I-vMBTFO8xWmOE2Gd4GsMaC0HXOK8XxQojgaqaEPGyWCGESUW4IK-LNzH-RAhxXJOL4qKhlFFGVsXvazhC58cehqS6bi5_wGHqVIK2vIMhuuSOLs2lt-V9mEc1-Oh7VeowGXD_RvJleoRyOyef_JMz5Y21YFJcTu2mXg3lzh0eq-u_fXO5d6Mfg0_ghrfFK6u6CO_O87J4uL253-6q_fev37Zf9pUhmKdKAxDKGKGiJYQbVddY8GbTKMtwQzkXmFrMEdFaaG2bDaWI5y3Sgmludb25LK5OvfneXxPEJHsXDXSdGsBPUeIGobppWAbXJ9AEH2MAK8fgehVmiZFcfMvFt1x8y8V3PvDx3DzpHtpn_Cw455_OuYpGdTaowbj4jG1YQzdsqflwwqzyUh1CRh7uRP4zJSKH_BRCVnR0EGQ0DgYDrQvZs2y9-9_z_gA8tqWQ</recordid><startdate>19950901</startdate><enddate>19950901</enddate><creator>Moore, D.R.</creator><creator>Smith, A.</creator><creator>Hager, K.M.</creator><creator>Waldon, R.</creator><creator>Esko, J.D.</creator><creator>Hajduk, S.L.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope></search><sort><creationdate>19950901</creationdate><title>Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein</title><author>Moore, D.R. ; Smith, A. ; Hager, K.M. ; Waldon, R. ; Esko, J.D. ; Hajduk, S.L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-bee4566459d448ca22198737af617588915f1804bb9bbf7355088040b96b8fb23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>ANIMAL DEVELOPMENTAL STAGES</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Biological Transport</topic><topic>BLOOD SERUM</topic><topic>Cell Differentiation</topic><topic>CYTOTOXICITY</topic><topic>Cytotoxins</topic><topic>Drug Resistance</topic><topic>Endocytosis</topic><topic>ETAPAS DEL DESARROLLO ANIMAL</topic><topic>Experimental protozoal diseases and models</topic><topic>Female</topic><topic>Fluorescent Antibody Technique</topic><topic>GENERO HUMANO</topic><topic>GENRE HUMAIN</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>LIPOPROTEINAS</topic><topic>LIPOPROTEINE</topic><topic>LIPOPROTEINS</topic><topic>Lipoproteins, HDL - metabolism</topic><topic>Lipoproteins, HDL - pharmacology</topic><topic>MANKIND</topic><topic>Medical sciences</topic><topic>Parasitic diseases</topic><topic>PROCYCLIC TRYPANOSOMES</topic><topic>Protein Binding</topic><topic>Protozoal diseases</topic><topic>Protozoan Proteins - biosynthesis</topic><topic>Rats</topic><topic>RESISTANCE</topic><topic>SERUM SANGUIN</topic><topic>STADE DE DEVELOPPEMENT ANIMAL</topic><topic>SUERO SANGUINEO</topic><topic>SUSCEPTIBILITY</topic><topic>TOXICIDAD</topic><topic>TOXICITE</topic><topic>TOXICITY</topic><topic>Toxicity Tests</topic><topic>Trypanocidal Agents - blood</topic><topic>Trypanocidal Agents - metabolism</topic><topic>Trypanocidal Agents - pharmacology</topic><topic>TRYPANOSOMA BRUCEI</topic><topic>Trypanosoma brucei brucei</topic><topic>Trypanosoma brucei brucei - drug effects</topic><topic>Trypanosoma brucei brucei - growth & development</topic><topic>Trypanosoma brucei brucei - ultrastructure</topic><topic>TRYPANOSOME LYTIC FACTOR</topic><topic>Variant Surface Glycoproteins, Trypanosoma - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moore, D.R.</creatorcontrib><creatorcontrib>Smith, A.</creatorcontrib><creatorcontrib>Hager, K.M.</creatorcontrib><creatorcontrib>Waldon, R.</creatorcontrib><creatorcontrib>Esko, J.D.</creatorcontrib><creatorcontrib>Hajduk, S.L.</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Experimental parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moore, D.R.</au><au>Smith, A.</au><au>Hager, K.M.</au><au>Waldon, R.</au><au>Esko, J.D.</au><au>Hajduk, S.L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein</atitle><jtitle>Experimental parasitology</jtitle><addtitle>Exp Parasitol</addtitle><date>1995-09-01</date><risdate>1995</risdate><volume>81</volume><issue>2</issue><spage>216</spage><epage>226</epage><pages>216-226</pages><issn>0014-4894</issn><eissn>1090-2449</eissn><coden>EXPAAA</coden><abstract>The bloodstream developmental stages of the protozoan parasite Trypanosoma brucei brucei are lysed by normal human serum. The cytotoxic factor is a minor sub-class of human high-density lipoprotein termed trypanosome lyric factor (TLF). T. b. brucei rapidly develops resistance to TLF when incubated at 26°C under conditions which allow differentiation to the procyclic, insect midgut developmental stage. This in vitro differentiation system allowed us to correlate loss of TLF sensitivity with other parameters of differentiation to the procyclic form. The onset of resistance to TLF occurs within 2 hr after shifting bloodstream forms to differentiation conditions. TLF resistance is correlated with a rapid but transient decrease in protein synthesis by the parasite, is acquired prior to cell division at 26°C, and precedes the loss of variant surface glycoprotein. Tn addition, we found binding and uptake of TLF by established procyclic trypanosomes was reduced approximately fivefold relative to bloodstream trypanosomes and the TLF binding observed in procyclics was nonspecific. No TLF was bound to the procyclic flagellar pocket membrane and the procyclics failed to endocytose any of the surface-bound TLF. In contrast, bloodstream forms bind TLF via a flagellar pocket-localized protein and bound TLF is taken up;by endocytosis. These findings suggest that resistance of procyclic T. b. brucei to TLF-mediated lysis is due to a reduction in the endocytosis of TLF by this developmental stage of the parasite.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>7556564</pmid><doi>10.1006/expr.1995.1111</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4894 |
ispartof | Experimental parasitology, 1995-09, Vol.81 (2), p.216-226 |
issn | 0014-4894 1090-2449 |
language | eng |
recordid | cdi_proquest_miscellaneous_17002776 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | ANIMAL DEVELOPMENTAL STAGES Animals Biological and medical sciences Biological Transport BLOOD SERUM Cell Differentiation CYTOTOXICITY Cytotoxins Drug Resistance Endocytosis ETAPAS DEL DESARROLLO ANIMAL Experimental protozoal diseases and models Female Fluorescent Antibody Technique GENERO HUMANO GENRE HUMAIN Humans Infectious diseases LIPOPROTEINAS LIPOPROTEINE LIPOPROTEINS Lipoproteins, HDL - metabolism Lipoproteins, HDL - pharmacology MANKIND Medical sciences Parasitic diseases PROCYCLIC TRYPANOSOMES Protein Binding Protozoal diseases Protozoan Proteins - biosynthesis Rats RESISTANCE SERUM SANGUIN STADE DE DEVELOPPEMENT ANIMAL SUERO SANGUINEO SUSCEPTIBILITY TOXICIDAD TOXICITE TOXICITY Toxicity Tests Trypanocidal Agents - blood Trypanocidal Agents - metabolism Trypanocidal Agents - pharmacology TRYPANOSOMA BRUCEI Trypanosoma brucei brucei Trypanosoma brucei brucei - drug effects Trypanosoma brucei brucei - growth & development Trypanosoma brucei brucei - ultrastructure TRYPANOSOME LYTIC FACTOR Variant Surface Glycoproteins, Trypanosoma - analysis |
title | Developmentally Regulated Sensitivity of Trypanosoma brucei brucei to the Cytotoxic Effects of Human High-Density Lipoprotein |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T20%3A27%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Developmentally%20Regulated%20Sensitivity%20of%20Trypanosoma%20brucei%20brucei%20to%20the%20Cytotoxic%20Effects%20of%20Human%20High-Density%20Lipoprotein&rft.jtitle=Experimental%20parasitology&rft.au=Moore,%20D.R.&rft.date=1995-09-01&rft.volume=81&rft.issue=2&rft.spage=216&rft.epage=226&rft.pages=216-226&rft.issn=0014-4894&rft.eissn=1090-2449&rft.coden=EXPAAA&rft_id=info:doi/10.1006/expr.1995.1111&rft_dat=%3Cproquest_cross%3E17002776%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17002776&rft_id=info:pmid/7556564&rft_els_id=S0014489485711113&rfr_iscdi=true |